Brian Culley
Company: Lineage Cell Therapeutic
Job title: Chief Executive Officer
Seminars:
Panel Discussion: Navigating What Design Elements are Needed to Optimize Clinical Trials for Dry AMD? 5:15 pm
Understanding the optimal inclusion and exclusion criteria Considering how the heterogenicity of clinical symptoms, diagnosis and manifestation should impact early and latestage clinical trial planning Assessing the feasibility of having smaller scale clinical trialsRead more
day: Conference Day 1
Delving into the Visual Function and Structural Changes of Patients in the Phase 1/2a OpRegen Study 9:30 am
Receiving a program update from the OpRegen program Assessing the available clinical data to understand OpRegen safety and preliminary activity Understanding the potential benefit of optical coherence tomography for assessing OpRegen activityRead more
day: Conference Day 1